SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-022256
Filing Date
2024-02-28
Accepted
2024-02-28 17:12:28
Documents
76
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cytk-20231231.htm   iXBRL 10-K 3569526
2 EX-10.6 cytk-ex10_6.htm EX-10.6 78311
3 EX-23.1 cytk-ex23_1.htm EX-23.1 6948
4 EX-31.1 cytk-ex31_1.htm EX-31.1 15128
5 EX-31.2 cytk-ex31_2.htm EX-31.2 14036
6 EX-32.1 cytk-ex32_1.htm EX-32.1 12399
7 EX-97.1 cytk-ex97_1.htm EX-97.1 49298
8 GRAPHIC img257646110_0.jpg GRAPHIC 35142
  Complete submission text file 0000950170-24-022256.txt   12999638

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cytk-20231231.xsd EX-101.SCH 1818290
78 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20231231_htm.xml XML 2141155
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50633 | Film No.: 24696813
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)